The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in......
The Indian Council of Medical Research's national task force for COVID-19 has decided against including antiviral drug Molnupiravir in the clinical management protocol for COVID-19 as of now,......
The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron. IMAGE: A nurse prepares......
The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to......
Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending......
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......
'Now is the time for India to course correct and for the government also to course correct,' says businessman Mangesh Khatri. Illustration: Dominic Xavier/Rediff.com The pandemic has caught......
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations. US pharmaceutical major Pfizer has......
As a result of the mass state-led scheme, the processes in the health insurance market could get simplified over time and become uniform Insurance Regulatory and Development Authority of India......
The European Medicines Agency’s review is the second setback to Alkem Laboratories. Alkem Laboratories has been accused by Germany’s health regulator of fudging data on clinical trials......